Document is current
Any future updates will be listed below
-
Authors
Provencio, Mariano http://orcid.org/0000-0001-9053-9197
Terrasa, Josefa
Garrido, Pilar
Campelo, Rosario García
Aparisi, Francisco
Diz, Pilar
Aguiar, David
García-Giron, Carlos
Hidalgo, Julia
Aguado, Carlos
González, Jorge García
Esteban, Emilio
Gómez-Aldavarí, Lorenzo
Moran, Teresa
Juan, Oscar
Chara, Luís Enrique
Marti, Juan L.
Castro, Rafael López
Ortega, Ana Laura
Moreno, Elia Martínez
Coves, Juan
Sánchez Peña, Ana M.
Bosch-Barrera, Joaquim
Gastaldo, Amparo Sánchez
Núñez, Natalia Fernández
del Barco, Edel
Cobo, Manuel
Isla, Dolores
Majem, Margarita
Navarro, Fátima
Calvo, Virginia http://orcid.org/0000-0002-3503-4847
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 20 September 2020
Accepted: 17 February 2021
First Online: 6 March 2021
Ethics approval and consent to participate
: The study was evaluated by the Ethical Committee of Hospital Universitario Puerta de Hierro de Majadahonda, Madrid. The study was also classified by the Spanish Health Authority as “EPA-OD” (post-authorization study, other designs). The study was carried out following the Declaration of Helsinki on Good Clinical Practices and Organic Law 3/2018, 5th December on Protection of Personal Data and digital rights that were guaranteed during the study. Alive patients have signed and dated an Institutional Review Board/Independent Ethics Committee (IRB/IEC)-approved written informed consent form in accordance with regulatory and institutional guidelines.
: Not applicable.
: A summary conflict of interest statement in a separate document.
